Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06351995 · ClinicalTrials.gov registry record · Phase 3
Neostigmine and Glycopyrrolate by Iontophoresis
A Phase 3 study of Spinal Cord Injuries and Constipation, sponsored by James J. Peters Veterans Affairs Medical Center.
- Active
- Registry status
- Phase 3
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT06351995 is a Phase 3 study of Spinal Cord Injuries and Constipation that is active but no longer recruiting, run by James J. Peters Veterans Affairs Medical Center. The registered enrollment target is 6 participants, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06351995, a Phase 3 study of Spinal Cord Injuries and Constipation, is active but no longer recruiting, sponsored by James J. Peters Veterans Affairs Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine a lower effective dose of neostigmine to induce bowel evacuation by transcutaneous administration by iontophoresis.
Conditions Studied
Interventions
- DRUG Combination of Neostigmine and Glycopyrrolate
- DEVICE I-Box by Dynatronics
Study Locations (1)
New York
- James J. Peters Veterans Affairs Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-11-06 |
| Est. Completion | 2025-01-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06351995
The ClinicalTrials.gov registry entry for NCT06351995 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (90% lower). The listed sponsor is James J. Peters Veterans Affairs Medical Center, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which Combination of Neostigmine and Glycopyrrolate is the first listed.
NCT06351995 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06351995 about?
NCT06351995 is a clinical study titled "Neostigmine and Glycopyrrolate by Iontophoresis". To determine a lower effective dose of neostigmine to induce bowel evacuation by transcutaneous administration by iontophoresis.
What is the current status of trial NCT06351995?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 6 participants. The study started on 2020-11-06. Estimated completion is 2025-01-01.
What conditions does trial NCT06351995 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Constipation, Fecal Incontinence, Neurogenic Bowel.
What interventions are being tested in trial NCT06351995?
The interventions under investigation include: Combination of Neostigmine and Glycopyrrolate (DRUG), I-Box by Dynatronics (DEVICE).
Who is sponsoring clinical trial NCT06351995?
This trial is sponsored by James J. Peters Veterans Affairs Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06351995 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury
COMPLETED · Phase 3
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.